Total Credits: 1 including 1 AOA Category 1-A Credit(s)
Carotid artery disease occurs when fatty deposits clog the blood vessels that deliver blood to your brain and head. Carotid artery disease develops slowly, and treatment of carotid artery disease usually involves a combination of lifestyle changes, medication and sometimes surgery. It is important that clinicians are aware of the current treatment options ranging from medical therapy to surgical therapy based upon data from the newest clinical trial and newer technologies commercially available.
At the conclusion of this session, the participant should be able to:
- Describe the different treatment options for carotid disease.
- Discuss the increasing role of medical management and to properly select patients for intervention.
- Develop a basic understanding of the different options for surgical interventions, their risk profiles, and the benefits and drawbacks of each approach.
Disclosure Statement: Dr. Loh, faculty for this educational event is on the speakers bureau for Cook Medical, Gore Medical and Silk Road. He serves on the advisory committee for Cook Medical and Medtronic. All relevant financial relationships listed have been mitigated.
Accreditation Statement: The Pennsylvania Osteopathic Medical Association (POMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. POMA designates this activity for a maximum of 1.0 Category 1-A AOA CME credits and will report CME and specialty credits to the AOA commensurate with the extent of the physician’s participation in this activity.
Grievance Statement: If you are not satisfied with the program, you may file a written grievance by emailing cme@poma.org. Your complaint will be forwarded to the Education Committee for review. The committee will determine if the participant should be reimbursed with no credits or deny the complaint and take the issue into consideration for future programs.
| LohShangHandout (5.4 MB) | Available after Purchase | ||
Shang Loh, MD, FACS, FSVS, “Current Medical, Endovascular and Surgical Management of Carotid Artery Disease,” is chief of vascular surgery and professor of clinical surgery at Penn Presbyterian Medical Center in Philadelphia. Board certified in general and vascular surgery, he is a graduate of University of California at Berkeley and a 2002 graduate of Texas A&M Health Science Center College of Medicine in College Station, Texas. He completed his general surgery and vascular surgery residency and fellowship at New York University Medical Center. A fellow of the American College of Surgeons and the Society for Vascular Surgery, Dr. Loh is a member of the Eastern Vascular Society, the New York Vascular Society, Vascular and Endovascular Surgery Society, and the Association of Program Directors in Vascular Surgery. Dr. Loh, faculty for this educational event, is on the speakers bureau for Cook Medical, Gore Medical and Silk Road. He serves on the advisory committee for Cook Medical and Medtronic.
All relevant financial relationships listed have been mitigated.
|
Current Screening for High School and College Athletes, Including Sudden Death in Sports
Original Program Date: 05/03/2023 |
|
Update in the Management of Congestive Heart Failure with Reduced Ejection Fraction in 2023
Original Program Date: 05/03/2023 |
|
An Interdisciplinary Approach to Metabolic Disease Management with Cultural Considerations
Original Program Date: 05/04/2023 |